CLINICAL TRIAL LOCATIONS

M. D. Anderson Cancer Center (MDACC)
http://www.mdanderson.org

The University of Texas M. D. Anderson Cancer Center (MDACC), located in Houston, Texas, is one of the world's most respected cancer centers and is often ranked as the best cancer hospital in the USA. The faculty numbers ~947 M.D.’s and Ph.D.s with a total staff of more than 12,000. In its 469-bed hospital it treats ~60,000 cancer patients per year of whom approximately 11,000 participate in clinical trials of new therapies, the largest such program in the U.S. The institution currently spends more than $250 million per year in research and ranks first in the number of cancer-related grants awarded nationwide by the National Cancer Institute. Clinical trials of Hum195/rGel are underway at the MDACC.

UCSD Cancer Center
http://cancer.ucsd.edu/About/cncover.asp

The Rebecca and John Moores UCSD Cancer Center is one of the leading cancer Centers in the U.S. Founded in 1979, UCSD Cancer Center is one of just 40 centers in the United States to hold a National Cancer Institute (NCI) designation as a Comprehensive Cancer Center. As such, it ranks among the top centers in the nation conducting basic and clinical cancer research, providing advanced patient care and serving the community through outreach and education programs. With a faculty membership of more than 255 physicians and scientists holding grants totaling over $88 million, the UCSD Cancer Center has approximately 200 open clinical trials and has » 20,000 patient visits per year. Clinical trials are planned at UCSD Cancer Center.